Zacks Investment Research on MSN
Natera files Signatera CDx PMA with FDA for bladder cancer MRD test
Natera NTRA recently announced the submission of a premarket approval (PMA) application to the FDA for its Signatera CDx test ...
Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...
News-Medical.Net on MSN
Color vision deficiency is linked to worse survival in bladder cancer
By Dr. Sanchari Sinha Dutta, Ph.D. A large electronic health record study suggests that difficulty recognizing painless blood ...
Out of sight, out of mind. A new study suggests a common eye condition could be quietly masking one of the only early warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results